Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cimicifuga + hypericum
- Development stage
- Unknown
- Lead developer
- Phytopharm Consulting
- Administration
- Oral
01
Overview
Cimicifuga + Hypericum (CIM/HIP) is a fixed-dose herbal combination therapy consisting of extracts from *Cimicifuga racemosa* (Black Cohosh) and *Hypericum perforatum* (St. John's Wort). Developed by Phytopharm Consulting Brazil, it is primarily indicated for the management of climacteric symptoms associated with perimenopause and menopause, such as hot flashes, irritability, and vasomotor complaints. The *Hypericum* component acts as a reuptake inhibitor of serotonin, norepinephrine, and dopamine, addressing psychological symptoms like mood swings and anxiety. The *Cimicifuga* component is thought to exert selective estrogen receptor modulating (SERM) effects or act via neurotransmitter pathways to alleviate vasomotor symptoms without the risks associated with traditional hormone replacement therapy. It has been evaluated in Phase 3 clinical trials (e.g., NCT01481025) comparing its efficacy to isolated Black Cohosh extracts.
- Brand names
- GynoPlusRemifeminPlus
- Other names
- Black Cohosh + St. John's WortCimicifuga racemosa + Hypericum perforatum
02
Targets
SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)ER (Estrogen receptor)
Beyond the preview
Go deeper on cimicifuga + hypericum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cimicifuga + hypericum.